Cite
HARVARD Citation
Heijmenberg, I. et al. (2021). ESX-5-targeted export of ESAT-6 in BCG combines enhanced immunogenicity & efficacy against murine tuberculosis with low virulence and reduced persistence. Vaccine. 39 (50), pp. 7265-7276. [Online].